HY-P99185-10mg
|
MedChemexpress LLC
|
Bapineuzumab [CAS 648895-38-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99185-5mg
|
MedChemexpress LLC
|
Bapineuzumab [CAS 648895-38-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-1mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-10mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-5mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99859-1mg
|
MedChemexpress LLC
|
Donanemab [CAS 1931944-80-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99859-10mg
|
MedChemexpress LLC
|
Donanemab [CAS 1931944-80-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99859-5mg
|
MedChemexpress LLC
|
Donanemab [CAS 1931944-80-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-1mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-10mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-5mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99648-1mg
|
MedChemexpress LLC
|
Gosuranemab [CAS 1788032-39-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99648-10mg
|
MedChemexpress LLC
|
Gosuranemab [CAS 1788032-39-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99648-5mg
|
MedChemexpress LLC
|
Gosuranemab [CAS 1788032-39-2]
|
|
Neuroscience-Neurodegeneration
|
|